EARNEST Partners’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $83.5M | Sell |
313,073
-7,861
| -2% | -$2.13M | 0.34% | 115 |
|
|
2025
Q4 | $80.5M | Sell |
320,934
-2,751
| -0.8% | -$731K | 0.35% | 114 |
|
|
2025
Q3 | $92.9M | Sell |
323,685
-7,799
| -2% | -$2.09M | 0.4% | 96 |
|
|
2025
Q2 | $87M | Buy |
331,484
+1,626
| +0.5% | +$396K | 0.39% | 100 |
|
|
2025
Q1 | $76.8M | Sell |
329,858
-8,867
| -3% | -$2.15M | 0.37% | 106 |
|
|
2024
Q4 | $77.7M | Sell |
338,725
-8,355
| -2% | -$1.92M | 0.35% | 111 |
|
|
2024
Q3 | $77.6M | Buy |
347,080
+22,810
| +7% | +$5.01M | 0.34% | 118 |
|
|
2024
Q2 | $66M | Sell |
324,270
-7,120
| -2% | -$1.45M | 0.31% | 127 |
|
|
2024
Q1 | $72.4M | Buy |
331,390
+68,347
| +26% | +$15.1M | 0.33% | 118 |
|
|
2023
Q4 | $59.8M | Sell |
263,043
-5,632
| -2% | -$1.18M | 0.3% | 123 |
|
|
2023
Q3 | $54M | Buy |
268,675
+49,607
| +23% | +$10.5M | 0.31% | 126 |
|
|
2023
Q2 | $39M | Sell |
219,068
-2,281
| -1% | -$442K | 0.22% | 150 |
|
|
2023
Q1 | $43.6M | Sell |
221,349
-142
| -0.1% | -$29.2K | 0.25% | 134 |
|
|
2022
Q4 | $44.8M | Buy |
221,491
+4,031
| +2% | +$788K | 0.27% | 128 |
|
|
2022
Q3 | $38.3M | Buy |
217,460
+4,180
| +2% | +$856K | 0.26% | 129 |
|
|
2022
Q2 | $42.9M | Buy |
213,280
+30,991
| +17% | +$6.61M | 0.29% | 119 |
|
|
2022
Q1 | $41.3M | Sell |
182,289
-3,654
| -2% | -$859K | 0.24% | 128 |
|
|
2021
Q4 | $50.2M | Sell |
185,943
-1,696
| -0.9% | -$420K | 0.29% | 119 |
|
|
2021
Q3 | $45.4M | Sell |
187,639
-8,693
| -4% | -$2.19M | 0.28% | 120 |
|
|
2021
Q2 | $46.5M | Sell |
196,332
-42
| -0% | -$9.57K | 0.27% | 123 |
|
|
2021
Q1 | $43M | Sell |
196,374
-3,948
| -2% | -$792K | 0.26% | 122 |
|
|
2020
Q4 | $35M | Sell |
200,322
-4,896
| -2% | -$846K | 0.24% | 123 |
|
|
2020
Q3 | $33.2M | Buy |
205,218
+10,602
| +5% | +$1.68M | 0.29% | 117 |
|
|
2020
Q2 | $27.8M | Sell |
194,616
-13,470
| -6% | -$1.86M | 0.26% | 119 |
|
|
2020
Q1 | $22.6M | Sell |
208,086
-1,375
| -0.7% | -$198K | 0.25% | 115 |
|
|
2019
Q4 | $30.4M | Buy |
209,461
+27,843
| +15% | +$4.02M | 0.24% | 124 |
|
|
2019
Q3 | $26.2M | Sell |
181,618
-759
| -0.4% | -$111K | 0.24% | 120 |
|
|
2019
Q2 | $27.1M | Buy |
182,377
+9,113
| +5% | +$1.27M | 0.24% | 124 |
|
|
2019
Q1 | $22.8M | Buy |
173,264
+8,169
| +5% | +$1.01M | 0.22% | 127 |
|
|
2018
Q4 | $17.9M | Buy |
165,095
+1,224
| +0.7% | +$164K | 0.2% | 135 |
|
|
2018
Q3 | $24.5M | Sell |
163,871
-5,599
| -3% | -$852K | 0.22% | 130 |
|
|
2018
Q2 | $26.1M | Sell |
169,470
-2,112
| -1% | -$319K | 0.24% | 123 |
|
|
2018
Q1 | $23.8M | Sell |
171,582
-1,919
| -1% | -$282K | 0.23% | 125 |
|
|
2017
Q4 | $23.8M | Sell |
173,501
-1,345
| -0.8% | -$178K | 0.23% | 124 |
|
|
2017
Q3 | $22.7M | Sell |
174,846
-4,157
| -2% | -$554K | 0.23% | 123 |
|
|
2017
Q2 | $23.7M | Sell |
179,003
-6,933
| -4% | -$849K | 0.25% | 118 |
|
|
2017
Q1 | $22.9M | Sell |
185,936
-309
| -0.2% | -$36.6K | 0.24% | 118 |
|
|
2016
Q4 | $20.5M | Sell |
186,245
-23,170
| -11% | -$2.57M | 0.22% | 127 |
|
|
2016
Q3 | $24.7M | Sell |
209,415
-5,380
| -3% | -$634K | 0.26% | 120 |
|
|
2016
Q2 | $24M | Sell |
214,795
-4,654
| -2% | -$501K | 0.26% | 118 |
|
|
2016
Q1 | $22.1M | Sell |
219,449
-3,946
| -2% | -$378K | 0.23% | 121 |
|
|
2015
Q4 | $23.7M | Sell |
223,395
-100,396
| -31% | -$10.4M | 0.24% | 117 |
|
|
2015
Q3 | $30.2M | Sell |
323,791
-36,423
| -10% | -$3.77M | 0.3% | 109 |
|
|
2015
Q2 | $37.5M | Buy |
360,214
+231,089
| +179% | +$24.1M | 0.33% | 105 |
|
|
2015
Q1 | $14M | Buy |
+129,125
| New | +$13.3M | 0.12% | 156 |
|
Other funds holding LH
VCM
VPM
EARNEST Partners's LH Position: Q1 2026 in Review
EARNEST Partners reduced its Labcorp (LH) stake by 2.4% in Q1 2026, selling an estimated $2.13M and leaving 313,073 shares worth $83.5M. The position accounts for 0.34% of the portfolio, ranked #115.
EARNEST Partners first reported a position in LH in Q1 2015 and has held it in 45 quarters since. The position peaked at $92.9M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- EARNEST Partners held 313,073 shares of Labcorp worth $83.5M as of Q1 2026.
- EARNEST Partners sold 7,861 Labcorp shares in Q1 2026, an estimated $2.13M.
- Labcorp made up 0.34% of EARNEST Partners's portfolio in Q1 2026, its #115 holding.
- EARNEST Partners first reported a position in Labcorp in Q1 2015 and has held it in 45 quarters since.
- EARNEST Partners's Labcorp position peaked at $92.9M in Q3 2025.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on EARNEST Partners's 13F filing for Q1 2026, filed 15 May 2026.